Global Antacids Market is Estimated at a Record USD 7.38 Billion by the End of 2030 | Infinium Global Research

Infinium Global Research proudly presents an extensive report shedding light on the global and regional Antacids Market, offering a comprehensive analysis of its segments and sub-segments. This comprehensive study encapsulates crucial market trends, forecasts, and dollar values while elucidating the impact of drivers, restraints, and macro indicators in both short and long-term scenarios.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1289

Market Overview:

The global antacids market, valued at USD 5.07 billion in 2022, is anticipated to surge to USD 7.38 billion by 2030, exhibiting a compelling Compound Annual Growth Rate (CAGR) of more than 4.11% during the forecast period 2023-2030.

Insights into Antacids:

Antacids, substances that neutralize stomach acidity, play a pivotal role in alleviating indigestion and upset stomachs. Combining various compounds with calcium, magnesium, and aluminum salts as active ingredients, antacids aid in neutralizing stomach acid and inhibiting proteolytic enzymes, offering relief from discomfort.

Driving Forces and Dynamics:

The escalating prevalence of digestive disorders stands as a primary driver for the antacids market. Conditions like Gastroesophageal Reflux Disease (GERD) and gastritis are on the rise, propelling the demand for antacid medications to manage associated symptoms. Additionally, evolving dietary habits, characterized by unhealthy eating patterns and stressful lifestyles, contribute to a higher incidence of gastrointestinal problems, further stimulating the market growth. Despite these drivers, concerns regarding potential side effects linked to antacid consumption pose challenges to market expansion. However, the development of innovative antacid products presents promising opportunities for market growth.

Regional Insights:

North America is anticipated to dominate the antacids market owing to its robust healthcare infrastructure and an aging demographic. With a well-established healthcare system, North America ensures easy access to medical services and pharmaceuticals like antacids, particularly as the elderly population rises. Similarly, the Asia Pacific region is poised to secure a significant market share driven by rapid economic development, an expanding middle-class population, and increased healthcare accessibility. Rising affluence and health-consciousness in countries like China and India fuel the demand for antacids.

Segments Covered:

The report encompasses segments such as drug class (proton pump inhibitor, h2 antagonist, acid neutralizers), formulation (tablet, liquid, powder), and distribution channel (hospital pharmacy, retail pharmacy, online pharmacy) within the global antacids market.

Key Companies Profiled:

Profiles of leading companies like GSK plc., Bayer AG, Pfizer Inc., Johnson & Johnson Services, Inc., Procter & Gamble, Acme United Corporation, Allegiant Health, Dr. Reddy's Laboratories Ltd., Reckitt Benckiser Group PLC, and WellSpring Pharmaceutical Corporation are featured in the report.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1289

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Antacids Market Highlights

2.2. Antacids Market Projection

2.3. Antacids Market Regional Highlights

Chapter 3. Global Antacids Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Drug Class

3.4.2. IGR-Growth Matrix Analysis by Formulation

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Antacids Market

Chapter 4. Antacids Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Antacids Market

5.2. Companies Profiles

5.2.1. GSK plc.

5.2.2. Bayer AG

5.2.3. Pfizer Inc.

5.2.4. Johnson & Johnson Services, Inc.

5.2.5. Procter & Gamble

5.2.6. Acme United Corporation

5.2.7. Allegiant Health

5.2.8. Dr. Reddy's Laboratories Ltd.

5.2.9. Reckitt Benckiser Group PLC

5.2.10. WellSpring Pharmaceutical Corporation

Chapter 6. Global Antacids Market by Drug Class

6.1. Proton Pump Inhibitor

6.2. H2 Antagonist

6.3. Acid Neutralizers

Chapter 7. Global Antacids Market by Formulation

7.1. Tablet

7.2. Liquid

7.3. Powder

Chapter 8. Global Antacids Market by Distribution Channel

8.1. Hospital Pharmacy

8.2. Retail Pharmacy

8.3. Online Pharmacy

Chapter 9. Global Antacids Market by Region 2023-2030

9.1. North America

9.1.1. North America Antacids Market by Drug Class

9.1.2. North America Antacids Market by Formulation

9.1.3. North America Antacids Market by Distribution Channel

9.1.4. North America Antacids Market by Country

9.1.4.1. The U.S. Antacids Market

9.1.4.1.1. The U.S. Antacids Market by Drug Class

9.1.4.1.2. The U.S. Antacids Market by Formulation

9.1.4.1.3. The U.S. Antacids Market by Distribution Channel

9.1.4.2. Canada Antacids Market

9.1.4.2.1. Canada Antacids Market by Drug Class

9.1.4.2.2. Canada Antacids Market by Formulation

9.1.4.2.3. Canada Antacids Market by Distribution Channel

9.1.4.3. Mexico Antacids Market

9.1.4.3.1. Mexico Antacids Market by Drug Class

9.1.4.3.2. Mexico Antacids Market by Formulation

9.1.4.3.3. Mexico Antacids Market by Distribution Channel

9.2. Europe

9.2.1. Europe Antacids Market by Drug Class

9.2.2. Europe Antacids Market by Formulation

9.2.3. Europe Antacids Market by Distribution Channel

9.2.4. Europe Antacids Market by Country

9.2.4.1. Germany Antacids Market

9.2.4.1.1. Germany Antacids Market by Drug Class

9.2.4.1.2. Germany Antacids Market by Formulation

9.2.4.1.3. Germany Antacids Market by Distribution Channel

9.2.4.2. United Kingdom Antacids Market

9.2.4.2.1. United Kingdom Antacids Market by Drug Class

9.2.4.2.2. United Kingdom Antacids Market by Formulation

9.2.4.2.3. United Kingdom Antacids Market by Distribution Channel

9.2.4.3. France Antacids Market

9.2.4.3.1. France Antacids Market by Drug Class

9.2.4.3.2. France Antacids Market by Formulation

9.2.4.3.3. France Antacids Market by Distribution Channel

9.2.4.4. Italy Antacids Market

9.2.4.4.1. Italy Antacids Market by Drug Class

9.2.4.4.2. Italy Antacids Market by Formulation

9.2.4.4.3. Italy Antacids Market by Distribution Channel

9.2.4.5. Rest of Europe Antacids Market

9.2.4.5.1. Rest of Europe Antacids Market by Drug Class

9.2.4.5.2. Rest of Europe Antacids Market by Formulation

9.2.4.5.3. Rest of Europe Antacids Market by Distribution Channel

9.3. Asia Pacific

9.3.1. Asia Pacific Antacids Market by Drug Class

9.3.2. Asia Pacific Antacids Market by Formulation

9.3.3. Asia Pacific Antacids Market by Distribution Channel

9.3.4. Asia Pacific Antacids Market by Country

9.3.4.1. China Antacids Market

9.3.4.1.1. China Antacids Market by Drug Class

9.3.4.1.2. China Antacids Market by Formulation

9.3.4.1.3. China Antacids Market by Distribution Channel

9.3.4.2. Japan Antacids Market

9.3.4.2.1. Japan Antacids Market by Drug Class

9.3.4.2.2. Japan Antacids Market by Formulation

9.3.4.2.3. Japan Antacids Market by Distribution Channel

9.3.4.3. India Antacids Market

9.3.4.3.1. India Antacids Market by Drug Class

9.3.4.3.2. India Antacids Market by Formulation

9.3.4.3.3. India Antacids Market by Distribution Channel

9.3.4.4. South Korea Antacids Market

9.3.4.4.1. South Korea Antacids Market by Drug Class

9.3.4.4.2. South Korea Antacids Market by Formulation

9.3.4.4.3. South Korea Antacids Market by Distribution Channel

9.3.4.5. Australia Antacids Market

9.3.4.5.1. Australia Antacids Market by Drug Class

9.3.4.5.2. Australia Antacids Market by Formulation

9.3.4.5.3. Australia Antacids Market by Distribution Channel

9.3.4.6. Rest of Asia-Pacific Antacids Market

9.3.4.6.1. Rest of Asia-Pacific Antacids Market by Drug Class

9.3.4.6.2. Rest of Asia-Pacific Antacids Market by Formulation

9.3.4.6.3. Rest of Asia-Pacific Antacids Market by Distribution Channel

9.4. RoW

9.4.1. RoW Antacids Market by Drug Class

9.4.2. RoW Antacids Market by Formulation

9.4.3. RoW Antacids Market by Distribution Channel

9.4.4. RoW Antacids Market by Sub-region

9.4.4.1. Latin America Antacids Market

9.4.4.1.1. Latin America Antacids Market by Drug Class

9.4.4.1.2. Latin America Antacids Market by Formulation

9.4.4.1.3. Latin America Antacids Market by Distribution Channel

9.4.4.2. Middle East Antacids Market

9.4.4.2.1. Middle East Antacids Market by Drug Class

9.4.4.2.2. Middle East Antacids Market by Formulation

9.4.4.2.3. Middle East Antacids Market by Distribution Channel

9.4.4.3. Africa Antacids Market

9.4.4.3.1. Africa Antacids Market by Drug Class

9.4.4.3.2. Africa Antacids Market by Formulation

9.4.4.3.3. Africa Antacids Market by Distribution Channel

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1289

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Antacids.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.